Low-Intensity Shockwave Therapy (LI-ESWT) in Diabetic Kidney Disease: Results from an Open-Label Interventional Clinical Trial

References

• Saeedi P, Petersohn I, Salpea P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9(th) edition. Diabetes Res Clin Pract. 2019;157:107843. doi:10.1016/j.diabres.2019.107843
   PubMed Web of Science ®Google Scholar
• Green A, Sortso C, Jensen PB, Emneus M. Incidence, morbidity, mortality, and prevalence of diabetes in Denmark, 2000–2011: results from the Diabetes Impact Study 2013. Clin Epidemiol. 2015;7:421–430. doi:10.2147/CLEP.S88577
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Standards of medical care in diabetes--2014. Diabetes Care. 2014;37(Suppl 1):S14–80. doi:10.2337/dc14-S014
   PubMed Web of Science ®Google Scholar
• de Boer IH, Rue TC, Hall YN, Heagerty PJ, Weiss NS, Himmelfarb J. Temporal trends in the prevalence of diabetic kidney disease in the United States. JAMA. 2011;305(24):2532–2539. doi:10.1001/jama.2011.861
   PubMed Web of Science ®Google Scholar
• Yan X, Zeng B, Chai Y, Luo C, Li X. Improvement of blood flow, expression of nitric oxide, and vascular endothelial growth factor by low-energy shockwave therapy in random-pattern skin flap model. Ann Plast Surg. 2008;61(6):646–653. doi:10.1097/SAP.0b013e318172ba1f
   PubMed Web of Science ®Google Scholar
• Fu M, Sun CK, Lin YC, et al. Extracorporeal shock wave therapy reverses ischemia-related left ventricular dysfunction and remodeling: molecular-cellular and functional assessment. PLoS One. 2011;6(9):e24342. doi:10.1371/journal.pone.0024342
   PubMed Web of Science ®Google Scholar
• Wang C-J, Ko J-Y, Kuo Y-R, Yang Y-J. Molecular changes in diabetic foot ulcers. Diabetes Res Clin Pract. 2011;94(1):105–110. doi:10.1016/j.diabres.2011.06.016
   PubMed Web of Science ®Google Scholar
• Aicher A, Heeschen C, Sasaki K, Urbich C, Zeiher AM, Dimmeler S. Low-energy shock wave for enhancing recruitment of endothelial progenitor cells: a new modality to increase efficacy of cell therapy in chronic hind limb ischemia. Circulation. 2006;114(25):2823–2830. doi:10.1161/CIRCULATIONAHA.106.628623
   PubMed Web of Science ®Google Scholar
• Gollmann-Tepekoylu C, Lobenwein D, Theurl M, et al. Shock wave therapy improves cardiac function in a model of chronic ischemic heart failure: evidence for a mechanism involving VEGF signaling and the extracellular matrix. J Am Heart Assoc. 2018;7(20):e010025. doi:10.1161/JAHA.118.010025
   PubMed Web of Science ®Google Scholar
• Lei PP, Tao SM, Shuai Q, et al. Extracorporeal cardiac shock wave therapy ameliorates myocardial fibrosis by decreasing the amount of fibrocytes after acute myocardial infarction in pigs. Coron Artery Dis. 2013;24(6):509–515. doi:10.1097/MCA.0b013e3283640ec7
   PubMed Web of Science ®Google Scholar
• Assaly R, Giuliano F, Clement P, et al. Extracorporeal shock waves therapy delivered by aries improves erectile dysfunction in spontaneously hypertensive rats through penile tissue remodeling and neovascularization. Sex Med. 2019;7(4):441–450. doi:10.1016/j.esxm.2019.08.006
   PubMed Web of Science ®Google Scholar
• Yang P, Guo T, Wang W, et al. Randomized and double-blind controlled clinical trial of extracorporeal cardiac shock wave therapy for coronary heart disease. Heart Vessels. 2013;28(3):284–291. doi:10.1007/s00380-012-0244-7
   PubMed Web of Science ®Google Scholar
• Cayton T, Harwood A, Smith GE, Chetter I. A systematic review of extracorporeal shockwave therapy as a novel treatment for intermittent claudication. Ann Vasc Surg. 2016;35:226–233. doi:10.1016/j.avsg.2016.02.017
   PubMed Web of Science ®Google Scholar
• Snyder R, Galiano R, Mayer P, Rogers LC, Alvarez O. Diabetic foot ulcer treatment with focused shockwave therapy: two multicentre, prospective, controlled, double-blinded, randomised Phase III clinical trials. J Wound Care. 2018;27(12):822–836. doi:10.12968/jowc.2018.27.12.822
   PubMed Web of Science ®Google Scholar
• EAU Guidelines. Edn. Presented at the EAU Annual Congress Amsterdam 2020. Arnhem, The Netherlands: EAU Guidelines Office; 2020. ISBN 978-94-92671-07-3.
   Google Scholar
• d’Agostino MC, Craig K, Tibalt E, Respizzi S. Shock wave as biological therapeutic tool: from mechanical stimulation to recovery and healing, through mechanotransduction. Int J Surg. 2015;24(PtB):147–153. doi:10.1016/j.ijsu.2015.11.030
   PubMed Web of Science ®Google Scholar
• Gerdesmeyer L, Maier M, Haake M, Schmitz C. Physikalisch-technische Grundlagen der extrakorporalen Stoßwellentherapie (ESWT) [Physical-technical principles of extracorporeal shockwave therapy (ESWT)]. Orthopade. 2002;31(7):610–617. German. doi:10.1007/s00132-002-0319-8
   Web of Science ®Google Scholar
• Ha CH, Kim S, Chung J, An SH, Kwon K. Extracorporeal shock wave stimulates expression of the angiogenic genes via mechanosensory complex in endothelial cells: mimetic effect of fluid shear stress in endothelial cells. Int J Cardiol. 2013;168(4):4168–4177. doi:10.1016/j.ijcard.2013.07.112
   PubMed Web of Science ®Google Scholar
• Hatanaka K, Ito K, Shindo T, et al. Molecular mechanisms of the angiogenic effects of low-energy shock wave therapy: roles of mechanotransduction. Am J Physiol Cell Physiol. 2016;311(3):C378–85. doi:10.1152/ajpcell.00152.2016
   PubMed Web of Science ®Google Scholar
• Holfeld J, Tepekoylu C, Reissig C, et al. Toll-like receptor 3 signalling mediates angiogenic response upon shock wave treatment of ischaemic muscle. Cardiovasc Res. 2016;109(2):331–343. doi:10.1093/cvr/cvv272
   PubMed Web of Science ®Google Scholar
• Sheu JJ, Ali HEE, Cheng BC, et al. Extracorporeal shock wave treatment attenuated left ventricular dysfunction and remodeling in mini-pig with cardiorenal syndrome. Oncotarget. 2017;8(33):54747–54763. doi:10.18632/oncotarget.18287
   Google Scholar
• Mariotto S, Cavalieri E, Amelio E, et al. Extracorporeal shock waves: from lithotripsy to anti-inflammatory action by NO production. Nitric Oxide. 2005;12(2):89–96. doi:10.1016/j.niox.2004.12.005
   PubMed Web of Science ®Google Scholar
• Abe Y, Ito K, Hao K, et al. Extracorporeal low-energy shock-wave therapy exerts anti-inflammatory effects in a rat model of acute myocardial infarction. Circ J. 2014;78(12):2915–2925. doi:10.1253/circj.CJ-14-0230
   Web of Science ®Google Scholar
• Kuo YR, Wang CT, Wang FS, Chiang YC, Wang CJ. Extracorporeal shock-wave therapy enhanced wound healing via increasing topical blood perfusion and tissue regeneration in a rat model of STZ-induced diabetes. Wound Repair Regen. 2009;17(4):522–530. doi:10.1111/j.1524-475X.2009.00504.x
   PubMed Web of Science ®Google Scholar
• Skov-Jeppesen SM, Yderstraede KB, Bistrup C, et al. Low-intensity shockwave therapy in the treatment of diabetic nephropathy: a prospective Phase 1 study. Nephrol Dial Transplant. 2018.
   Web of Science ®Google Scholar
• Zhang X, Krier JD, Amador Carrascal C, et al. Low-energy shockwave therapy improves ischemic kidney microcirculation. J Am Soc Nephrol. 2016;27(12):3715–3724. doi:10.1681/ASN.2015060704
   PubMed Web of Science ®Google Scholar
• Yoshida M, Nakamichi T, Mori T, Ito K, Shimokawa H, Ito S. Low-energy extracorporeal shock wave ameliorates ischemic acute kidney injury in rats. Clin Exp Nephrol. 2019;23(5):597–605. doi:10.1007/s10157-019-01689-7
   PubMed Web of Science ®Google Scholar
• Sung PH, Chen KH, Li YC, Chiang JY, Lee MS, Yip HK. Sitagliptin and shock wave-supported peripheral blood derived endothelial progenitor cell therapy effectively preserves residual renal function in chronic kidney disease in rat-role of dipeptidyl peptidase 4 inhibition. Biomed Pharmacother. 2019;111:1088–1102. doi:10.1016/j.biopha.2019.01.025
   PubMed Web of Science ®Google Scholar
• Hsiao CC, Huang WH, Cheng KH, Lee CT. Low-energy extracorporeal shock wave therapy ameliorates kidney function in diabetic nephropathy. Oxid Med Cell Longev. 2019;2019:8259645. doi:10.1155/2019/8259645
   PubMed Web of Science ®Google Scholar
• Caron J, Michel PA, Dussaule JC, Chatziantoniou C, Ronco P, Boffa JJ. Extracorporeal shock wave therapy does not improve hypertensive nephropathy. Physiol Rep. 2016;4(11):11. doi:10.14814/phy2.12699
   Google Scholar
• Zhao Y, Santelli A, Zhu XY, et al. Low-energy shockwave treatment promotes endothelial progenitor cell homing to the stenotic pig kidney. Cell Transplant. 2020;29:963689720917342. doi:10.1177/0963689720917342
   PubMed Web of Science ®Google Scholar
• Aksoy H, Aksoy Y, Turhan H, Keles S, Ziypak T, Ozbey I. The effect of shock wave lithotripsy on nitric oxide and malondialdehyde levels in plasma and urine samples. Cell Biochem Funct. 2007;25(5):533–536. doi:10.1002/cbf.1349
   PubMed Web of Science ®Google Scholar
• Park JK, Cui Y, Kim HJ, Oh HK, Koh GY, Cho KW. Activation of nitric oxide-cyclic guanosine monophosphate signaling in kidney by extracorporeal shock wave therapy. J Urol. 2003;170(6 Pt 1):2459–2462. doi:10.1097/01.ju.0000094186.19728.c2
   Web of Science ®Google Scholar
• Lee FC, Hsi RS, Sorensen MD, et al. Renal vasoconstriction occurs early during shockwave lithotripsy in humans. J Endourol. 2015;29(12):1392–1395. doi:10.1089/end.2015.0315
   PubMed Web of Science ®Google Scholar
• Griffin BR, Faubel S, Edelstein CL. Biomarkers of drug-induced kidney toxicity. Ther Drug Monit. 2019;41(2):213–226. doi:10.1097/FTD.0000000000000589
   PubMed Web of Science ®Google Scholar
• Yu Y, Jin H, Holder D, et al. Urinary biomarkers trefoil factor 3 and albumin enable early detection of kidney tubular injury. Nat Biotechnol. 2010;28(5):470–477. doi:10.1038/nbt.1624
   PubMed Web of Science ®Google Scholar
• Wadey RM, Pinches MG, Jones HB, Riccardi D, Price SA. Tissue expression and correlation of a panel of urinary biomarkers following cisplatin-induced kidney injury. Toxicol Pathol. 2014;42(3):591–602. doi:10.1177/0192623313492044
   Web of Science ®Google Scholar
• Lebherz-Eichinger D, Tudor B, Ankersmit HJ, et al. Trefoil factor 1 excretion is increased in early stages of chronic kidney disease. PLoS One. 2015;10(9):e0138312. doi:10.1371/journal.pone.0138312
   Web of Science ®Google Scholar
• Xue Y, Xu Z, Chen H, Gan W, Chong T. Low-energy shock wave preconditioning reduces renal ischemic reperfusion injury caused by renal artery occlusion. Acta Cir Bras. 2017;32(7):550–558. doi:10.1590/s0102-865020170070000006
   PubMed Web of Science ®Google Scholar
• Chen XJ, Zhang X, Jiang K, et al. Improved renal outcomes after revascularization of the stenotic renal artery in pigs by prior treatment with low-energy extracorporeal shockwave therapy. J Hypertens. 2019;37(10):2074–2082. doi:10.1097/HJH.0000000000002158
   Web of Science ®Google Scholar
• Nakamura A, Ishii A, Ohata C, Komurasaki T. Early induction of osteoactivin expression in rat renal tubular epithelial cells after unilateral ureteral obstruction. Exp Toxicol Pathol. 2007;59(1):53–59. doi:10.1016/j.etp.2007.03.005
   Google Scholar
• Chen S, Ziyadeh FN. Vascular endothelial growth factor and diabetic nephropathy. Curr Diab Rep. 2008;8(6):470–476. doi:10.1007/s11892-008-0081-3
   Web of Science ®Google Scholar
• Majumder S, Advani A. VEGF and the diabetic kidney: more than too much of a good thing. J Diabetes Complications. 2017;31(1):273–279. doi:10.1016/j.jdiacomp.2016.10.020
   PubMed Web of Science ®Google Scholar
• Nakagawa T, Sato W, Kosugi T, Johnson RJ. Uncoupling of VEGF with endothelial NO as a potential mechanism for abnormal angiogenesis in the diabetic nephropathy. J Diabetes Res. 2013;2013:184539. doi:10.1155/2013/184539
   PubMed Web of Science ®Google Scholar
• Andresdottir G, Jensen ML, Carstensen B, et al. Improved prognosis of diabetic nephropathy in type 1 diabetes. Kidney Int. 2015;87(2):417–426. doi:10.1038/ki.2014.206
   Web of Science ®Google Scholar
• Andresdottir G, Jensen ML, Carstensen B, et al. Improved survival and renal prognosis of patients with type 2 diabetes and nephropathy with improved control of risk factors. Diabetes Care. 2014;37(6):1660–1667. doi:10.2337/dc13-2036
   Web of Science ®Google Scholar